<div dir="auto"></div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">---------- Forwarded message ---------<br>From: <strong class="gmail_sendername" dir="auto">Orengo, Christine</strong> <span dir="auto"><<a href="mailto:c.orengo@ucl.ac.uk">c.orengo@ucl.ac.uk</a>></span><br>Date: Fri, 22 Jul 2022, 21:35<br>Subject: 3D-BioInfo AGM 2022     2 - 4th November EBI Hinxton Hybrid Meeting<br>To: 3d-bioinfo-all-contacts <<a href="mailto:3d-bioinfo-all-contacts@live.ucl.ac.uk">3d-bioinfo-all-contacts@live.ucl.ac.uk</a>><br></div><br><br>




<div dir="ltr">
<div style="font-size:12pt;color:rgb(0,0,0)">
<p class="MsoNormal" style="font-family:Calibri,sans-serif;font-size:11pt;margin:18pt 0cm 12pt;background:rgb(254,254,254)">
<span style="font-size:10pt;font-family:Lato,sans-serif;color:black">Dear All,</span></p>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;font-size:11pt;margin:18pt 0cm 12pt;background:rgb(254,254,254)">
<span style="color:black;font-family:Lato,sans-serif;font-size:10pt">The 2022 ELIXIR 3D BioInfo F2F/hybrid meeting, the Communities Annual General Meeting takes place from:</span><br>
</p>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;font-size:11pt;margin:18pt 0cm 12pt;background:rgb(254,254,254)">
<span style="font-size:10pt;font-family:Lato,sans-serif;color:black"><b>2 November 2022,  12:00 GMT to 4 November 2022,  14:00 GMT. 
</b></span><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:black"><br>
<br>
</span><span style="font-size:10pt;font-family:Lato,sans-serif;color:black">This meeting is planned as a hybrid meeting, with the F2F component at the Wellcome Genome Campus, Hinxton, UK. </span><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:black"><u></u><span style="font-size:10pt"> </span><u></u></span></p>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
<span style="font-size:10pt;font-family:Lato,sans-serif;color:black">The meeting will include presentations, workshops and participant engagement and will focus on the five Community activities: ​</span><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:black"><u></u><span style="font-size:10pt"> </span><u></u></span></p>
<ol type="1" style="font-family:Calibri,Arial,Helvetica,sans-serif;margin-bottom:0cm">
<li style="display:block;font-size:10pt"><span style="font-size:10pt"></span></li><li class="MsoNormal" style="margin:0cm 0cm 8pt;font-size:10pt;font-family:Calibri,sans-serif;color:black;background:#fefefe">
<span style="font-size:10pt;font-family:Lato,sans-serif">FAIR infrastructure for protein 3D-models and associated structural and functional annotations</span><span style="font-size:12.0pt;font-family:"Lato",sans-serif"><u></u><span style="font-size:10pt"> </span><u></u></span></li><li style="display:block;font-size:10pt"><span style="font-size:10pt"></span></li><li class="MsoNormal" style="margin:0cm 0cm 8pt;font-size:10pt;font-family:Calibri,sans-serif;color:black;background:#fefefe">
<span style="font-size:10pt;font-family:Lato,sans-serif">Open resources for sharing, integrating and benchmarking software tools for modelling the Interactome in 3D</span><span style="font-size:12.0pt;font-family:"Lato",sans-serif"><u></u><span style="font-size:10pt"> </span><u></u></span></li><li style="display:block;font-size:10pt"><span style="font-size:10pt"></span></li><li class="MsoNormal" style="margin:0cm 0cm 8pt;font-size:10pt;font-family:Calibri,sans-serif;color:black;background:#fefefe">
<span style="font-size:10pt;font-family:Lato,sans-serif">Development of models for protein-ligand interactions</span><span style="font-size:12.0pt;font-family:"Lato",sans-serif"><u></u><span style="font-size:10pt"> </span><u></u></span></li><li style="display:block;font-size:10pt"><span style="font-size:10pt"></span></li><li class="MsoNormal" style="margin:0cm 0cm 8pt;font-size:10pt;font-family:Calibri,sans-serif;color:black;background:#fefefe">
<span style="font-size:10pt;font-family:Lato,sans-serif">Nucleic Acid Tools: Progress and further plans</span><span style="font-size:12.0pt;font-family:"Lato",sans-serif"><u></u><span style="font-size:10pt"> </span><u></u></span></li><li style="display:block;font-size:10pt"><span style="font-size:10pt"></span></li><li class="MsoNormal" style="margin:0cm 0cm 8pt;font-size:10pt;font-family:Calibri,sans-serif;color:black;background:#fefefe">
<span style="font-size:10pt;font-family:Lato,sans-serif">Protein Engineering</span><span style="font-size:12.0pt;font-family:"Lato",sans-serif"><u></u><span style="font-size:10pt"> </span><u></u></span></li></ol>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
<span style="font-size:10pt;font-family:Lato,sans-serif;color:black">More details can be found on the </span><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:black"><a href="https://elixir-europe.org/communities/3d-bioinfo" target="_blank" rel="noreferrer"><span style="color:rgb(4,126,170);font-size:10pt">Community
 website</span></a></span><span style="font-size:10pt;font-family:Lato,sans-serif;color:black">. The agenda will be published soon. </span><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:black"><u></u><span style="font-size:10pt"> </span><u></u></span></p>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
<span style="font-size:10pt;font-family:Lato,sans-serif;color:black">This meeting has a limit of 80 in-person attendees, with no-limit on virtual participant numbers. </span></p>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
</p>
<p class="MsoNormal" style="margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
<span style="font-family:Lato,sans-serif;font-size:10pt;color:black">We are inviting submission of abstracts to give a talk or present a poster. </span><span style="font-size:12pt;color:black"><u></u><span style="font-size:10pt"><font face="Lato, sans-serif"> </font></span><u></u></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
<span style="font-size:12pt;color:black"><u></u><span style="font-size:10pt"><span style="font-size:10pt;margin:0px;color:black"><font face="Lato, sans-serif"><span style="font-size:10pt">A selected number of participants invited to</span><span style="font-size:11pt"> </span></font></span></span><u></u></span><span style="color:black;font-family:Calibri,sans-serif;font-size:11pt">speak
 or present a poster will be eligible to receive funding to attend the meeti</span><span style="color:black;font-family:Calibri,sans-serif;font-size:11pt">ng. </span><span style="color:black;font-family:Calibri,sans-serif;font-size:12pt"><u></u><span style="font-size:11pt"> </span><u></u></span></p>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
<b><span style="font-size:10pt;font-family:Lato,sans-serif;color:black">Deadline: 12 August 2022</span><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:black"><u></u><span style="font-size:10pt"> </span><u></u></span></b></p>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
<span style="font-size:10pt;font-family:Lato,sans-serif;color:black">Click on the "submit an abstract" link below for more information on the abstract submission.</span><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:black"><u></u><span style="font-size:10pt"> </span><u></u></span></p>
<p class="MsoNormal" style="font-family:Calibri,sans-serif;margin:0cm 0cm 12pt;font-size:11pt;background:rgb(254,254,254)">
<b><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:#333333"><a href="https://elixir-europe.us4.list-manage.com/track/click?u=751beffce2e491f94d6f66918&id=4e7ce819ae&e=9263753faa" target="_blank" rel="noreferrer"><span style="color:rgb(4,126,170);font-size:10pt">Submit
 an abstract by 12 August 2022</span></a></span></b><span style="font-size:12.0pt;font-family:"Lato",sans-serif;color:black"><u></u><span style="font-size:10pt"> </span><u></u></span></p>
<font face="Calibri, Arial, Helvetica, sans-serif">We hope you will consider participating in the meeting.</font></div>
<div style="font-family:Calibri,Arial,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div style="font-family:Calibri,Arial,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Best Wishes</div>
<div style="font-family:Calibri,Arial,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
Christine Orengo, Sameer Velankar, Shoshana Wodak, Bohdan Schneider, Vincent Zoete, Lynne Regan</div>
<div style="font-family:Calibri,Arial,Helvetica,sans-serif;font-size:12pt;color:rgb(0,0,0)">
<br>
</div>
<div id="m_-674424228101023544a59ada49-a492-4f1d-ac57-74be3a4194fc" style="display:inline-block">
<table cellspacing="0" style="table-layout:fixed;width:50px;border:0 none black">
<tbody>
<tr>
<td style="height:18px;padding:0;border-width:0 0 1px 0;border-style:none none solid none;border-color:#eaeaea">
 </td>
</tr>
</tbody>
</table>
<table cellspacing="0" style="table-layout:fixed;width:90%;line-height:17px;border:0 none black">
<tbody>
<tr>
<td style="height:17px;padding:0;border:0 none black"> </td>
</tr>
<tr>
<td style="padding:0;border:0 none black;color:#666666;font-size:12px;font-family:'Segoe UI','Segoe WP',sans-serif">
You're receiving this message because you're a member of the 3d-bioinfo-all-contacts group from University College London. To take part in this conversation, reply all to this message.</td>
</tr>
<tr>
<td style="height:17px;padding:0;border:0 none black"> </td>
</tr>
<tr>
<td style="padding:0;border:0 none black;font-size:12px;font-family:'Segoe UI','Segoe WP',sans-serif">
<span style="display:inline-block"><a style="color:#666666;text-decoration:none;font-size:12px;font-family:'Segoe UI','Segoe WP',sans-serif" href="https://outlook.office365.com/owa/3d-bioinfo-all-contacts@live.ucl.ac.uk/groupsubscription.ashx?source=EscalatedMessage&action=files&GuestId=05d85403-979f-4949-9c44-24eab7e8d60d" target="_blank" rel="noreferrer">View group files</a></span><span style="color:#c8c8c8">   |   </span><span style="display:inline-block"><a style="color:#666666;text-decoration:none;font-size:12px;font-family:'Segoe UI','Segoe WP',sans-serif" id="m_-674424228101023544BD5134C6-8D33-4ABA-A0C4-08581FDF89DB" href="https://outlook.office365.com/owa/3d-bioinfo-all-contacts@live.ucl.ac.uk/groupsubscription.ashx?source=EscalatedMessage&action=leave&GuestId=05d85403-979f-4949-9c44-24eab7e8d60d" target="_blank" rel="noreferrer">Leave group</a></span><span style="color:#c8c8c8">   |   </span><span style="display:inline-block"><a style="color:#666666;text-decoration:none;font-size:12px;font-family:'Segoe UI','Segoe WP',sans-serif" href="https://aka.ms/o365g" target="_blank" rel="noreferrer">Learn
 more about Microsoft 365 Groups</a></span></td>
</tr>
<tr>
<td style="height:17px;padding:0;border:0 none black"> </td>
</tr>
</tbody>
</table>
</div>
</div>

</div>